These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25306745)

  • 1. [Pharmacoeconomic evaluation of treatment in patients with Helicobacter pylori-associated diseases].
    Samsonov AA; Grechushnikov VB; Andreev DN; Iurenev GL; Korovina TI; Lezhneva IuA; Maev IV
    Ter Arkh; 2014; 86(8):56-61. PubMed ID: 25306745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection.
    Yurenev GL; Partzvania-Vinogradova EV; Andreev DN; Dicheva DT; Maiev IV
    Ter Arkh; 2018 Aug; 90(8):33-39. PubMed ID: 30701937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
    Vakil N; Fennerty MB
    Am J Gastroenterol; 1996 Feb; 91(2):239-45. PubMed ID: 8607487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients.
    Park HG; Jung MK; Jung JT; Kwon JG; Kim EY; Seo HE; Lee JH; Yang CH; Kim ES; Cho KB; Park KS; Lee SH; Kim KO; Jeon SW
    Aliment Pharmacol Ther; 2012 Jan; 35(1):56-65. PubMed ID: 22066530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of hybrid and sequential therapies for Helicobacter pylori eradication in Iran: a prospective randomized trial.
    Sardarian H; Fakheri H; Hosseini V; Taghvaei T; Maleki I; Mokhtare M
    Helicobacter; 2013 Apr; 18(2):129-34. PubMed ID: 23121338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the dyspeptic patient: a cost-utility study.
    Ebell MH; Warbasse L; Brenner C
    J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer].
    Butorov IV; Osoianu IuP; Butorov SI; Maksimov VV
    Klin Med (Mosk); 2005; 83(12):50-3. PubMed ID: 16502725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
    Stack WA; Knifton A; Thirlwell D; Cockayne A; Jenkins D; Hawkey CJ; Atherton JC
    Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
    Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
    Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the efficacy and the cost-effectiveness of proton pump inhibitor-based dual and triple therapy regimens for H. pylori eradication in peptic ulcer disease].
    Habu Y; Kiyota K; Inokuchi H; Sugano Y; Ko K; Waki S
    Nihon Rinsho; 1999 Jan; 57(1):135-9. PubMed ID: 10036950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing.
    Forné M; Viver JM; Esteve M; Fernández-Bañares F; Lite J; Espinós JC; Quintana S; Salas A; Garau J
    Am J Gastroenterol; 1998 Jan; 93(1):35-8. PubMed ID: 9448170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia.
    De Francesco V; Della Valle N; Stoppino V; Amoruso A; Muscatiello N; Panella C; Ierardi E
    Aliment Pharmacol Ther; 2004 May; 19(9):993-8. PubMed ID: 15113366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quadruple therapy with ecabet sodium, omeprazole, amoxicillin and metronidazole is effective for eradication of Helicobacter pylori after failure of first-line therapy (KDOG0201 Study).
    Koizumi W; Tanabe S; Nakatani K; Ishido K; Nishimura K; Azuma M; Ae T; Sasaki T; Higuchi K; Katada C; Nakayama N; Saigenji K
    J Clin Pharm Ther; 2010 Jun; 35(3):303-7. PubMed ID: 20831531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease--A pilot study.
    Lüth S; Teyssen S; Kölbel CB; Singer MV
    Z Gastroenterol; 2001 Apr; 39(4):279-81, 284-5. PubMed ID: 11367976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
    Kearney DJ; Liu CF; Crump C; Brousal A
    Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease.
    Jönsson B
    Scand J Gastroenterol Suppl; 1996; 215():90-5. PubMed ID: 8722390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice.
    McNicholl AG; Marin AC; Molina-Infante J; Castro M; Barrio J; Ducons J; Calvet X; de la Coba C; Montoro M; Bory F; Perez-Aisa A; Forné M; Gisbert JP;
    Gut; 2014 Feb; 63(2):244-9. PubMed ID: 23665990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.